Targeting Tumors: How Dye Drug Conjugates Are Revolutionizing Cancer Treatment
Finding Genius Podcast
Richard Jacobs
4.4 • 1K Ratings
🗓️ 9 October 2024
⏱️ 30 minutes
🧾️ Download transcript
Summary
In today's episode, we sit down with Lyle Small to discuss cutting-edge methods of enhancing cancer treatments. Lyle is the founder and current CEO of Lahjavida, Inc., a cancer research firm focused on developing new cancer treatments. Known for their patented invention of a new cancer treatment, Lahjavida utilizes the tumor-targeting capabilities of NIR fluorescent dyes to work in conjunction with therapeutic agents – thus enhancing the effectiveness of a given therapy…
With an engineering degree from Cornell, Lyle has a diverse background in entrepreneurship. He served as the Founder and CEO of Chromatic Technologies, Inc. for more than 30 years, a company that pioneered several breakthroughs in the dye industry. Now, he leverages his extensive experience and knowledge to help in the battle against cancer.
What role does dye play in the identification and treatment of cancer? Join us now to find out for yourself!
Jump in to learn about:
- How Lyle's experience has contributed to Lahjavida's work.
- What dye chemists are, and their role in developing various medical technologies.
- What you need to know about Dye Drug Conjugates (DDCs).
- The holy grail of cancer treatment.
To follow along with Lyle's work with Lahjavida, click here!
Episode also available on Apple Podcasts: http://apple.co/30PvU9
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Forget frequently asked questions. |
| 0:02.0 | Common sense, common knowledge, or Google. |
| 0:05.0 | How about advice from a real genius? |
| 0:07.0 | 95% of people in any profession are good enough to be qualified and licensed. |
| 0:11.0 | 5% go above and beyond. They become very good at what they do. |
| 0:15.0 | But only 0.1% are real Jesus. |
| 0:18.2 | Richard Jacobs has made it his life's mission to find them for you. |
| 0:22.2 | He hunts down and interviews geniuses in every |
| 0:24.6 | field, sleep science, cancer, stem cells, ketogenic diets and more. Here come the geniuses. |
| 0:30.0 | This is the Finding Genius Podcast. |
| 0:33.0 | That are Richard Jacobs. |
| 0:35.0 | Hello, this is Richard Jacobs with the Finding Genius Podcast. |
| 0:41.0 | My guest today is Lyle Small. he's the founder and interim chief technology |
| 0:45.5 | officer of a topic called Die Drug Conjug Congregates, DDCs. They developed a proprietary enhanced chemotherapy delivery platform known as a dye drug |
| 0:57.1 | conjugates, as a tumor targeting dye, other aspects of it that I'll let him describe |
| 1:02.0 | so I don't screw them up. |
| 1:03.2 | But regardless, welcome Lyle. |
| 1:05.0 | Thanks for coming. |
| 1:05.9 | Thank you, Ritz, appreciate it. |
| 1:07.3 | Yeah. |
| 1:08.3 | Well, if you will tell me just a little bit about your background and then how you got to work |
| 1:11.9 | with these DDCs and with chemotherapy. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.